Literature DB >> 20458739

MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes.

Xiao-Wei Song1, Qing Li, Li Lin, Xiao-Chen Wang, Dong-Feng Li, Guo-Kun Wang, An-Jing Ren, Yan-Rong Wang, Yong-Wen Qin, Wen-Jun Yuan, Qing Jing.   

Abstract

Cardiac hypertrophy, which is characterized by an increase in cell size and reactivation of fetal genes, occurs as an adaptive response to diverse forms of stress and often results in heart failure and sudden death. Growing evidence indicates that microRNAs (miRNAs) are involved in cardiac hypertrophy, but the function of these miRNAs remains elusive. Here, using real time PCR analysis, we showed that several miRNAs were dynamically regulated in the rat hypertrophic hearts and miR-199a was up-regulated by 10-fold in hypertrophic hearts after abdominal aorta constriction for 12 weeks. With tissue profiling analysis, we showed that miR-199a was predominantly expressed in cardiomyocytes, but was also faintly detected in cardiac fibroblasts. To investigate whether miR-199a was involved in cardiac hypertrophy, both over-expression and knockdown of miR-199a were performed in cultured cardiomyocytes. Over-expression of miR-199a in cardiomyocytes increased the cell size as measured by cell surface area, and also reduced the mRNA expression level of alpha-myosin heavy chain. In accordance, knockdown of endogenous miR-199a in cardiomyocytes reduced the cell size. Down-regulation of miR-199a also attenuated the phenylephrine-induced increase of cell size. Furthermore, bioinformatic algorithms were used to predict the potential targets of miR-199a in cardiac hypertrophy, and hypoxia-inducible factor 1 alpha was confirmed by the luciferase reporter assay to be a potential target of miR-199a. Taken together, our results demonstrated that miR-199a, which was predominantly expressed in cardiomyocytes, was essential for the maintenance of cell size of cardiomyocytes and might play a role in the regulation of cardiac hypertrophy. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20458739     DOI: 10.1002/jcp.22217

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  51 in total

1.  Cardiac hypertrophy is positively regulated by long non-coding RNA PVT1.

Authors:  Yi-Hui Yu; Zuo-Ying Hu; Ming-Hui Li; Bing Li; Zhi-Mei Wang; Shao-Liang Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 2.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

3.  MicroRNA MiR-199a-5p regulates smooth muscle cell proliferation and morphology by targeting WNT2 signaling pathway.

Authors:  Ali Hashemi Gheinani; Fiona C Burkhard; Hubert Rehrauer; Catharine Aquino Fournier; Katia Monastyrskaya
Journal:  J Biol Chem       Date:  2015-01-16       Impact factor: 5.157

4.  Epitranscriptional orchestration of genetic reprogramming is an emergent property of stress-regulated cardiac microRNAs.

Authors:  Yuanxin Hu; Scot J Matkovich; Peter A Hecker; Yan Zhang; John R Edwards; Gerald W Dorn
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-12       Impact factor: 11.205

5.  miRNA overexpression induces cardiomyocyte proliferation in vivo.

Authors:  Andrew H Baker; Eva van Rooij
Journal:  Mol Ther       Date:  2013-03       Impact factor: 11.454

6.  Cell-specific detection of microRNA expression during cardiomyogenesis by combined in situ hybridization and immunohistochemistry.

Authors:  Mikael Schneider; Ditte Caroline Andersen; Asli Silahtaroglu; Stig Lyngbæk; Sakari Kauppinen; Jakob Lerche Hansen; Søren Paludan Sheikh
Journal:  J Mol Histol       Date:  2011-06-05       Impact factor: 2.611

7.  Chronic treatment of mice with leukemia inhibitory factor does not cause adverse cardiac remodeling but improves heart function.

Authors:  Carlos Zgheib; Fouad Anthony Zouein; Mazen Kurdi; George Warren Booz
Journal:  Eur Cytokine Netw       Date:  2012 Oct-Dec       Impact factor: 2.737

8.  MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia.

Authors:  Ulrike Bruning; Luca Cerone; Zoltan Neufeld; Susan F Fitzpatrick; Alex Cheong; Carsten C Scholz; David A Simpson; Martin O Leonard; Murtaza M Tambuwala; Eoin P Cummins; Cormac T Taylor
Journal:  Mol Cell Biol       Date:  2011-08-01       Impact factor: 4.272

Review 9.  miRNome in myocardial infarction: Future directions and perspective.

Authors:  Emanuela Boštjančič; Damjan Glavač
Journal:  World J Cardiol       Date:  2014-09-26

10.  The microRNA miR-199a-5p down-regulation switches on wound angiogenesis by derepressing the v-ets erythroblastosis virus E26 oncogene homolog 1-matrix metalloproteinase-1 pathway.

Authors:  Yuk Cheung Chan; Sashwati Roy; Yue Huang; Savita Khanna; Chandan K Sen
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.